- Home
- FHTX vs PGC Comparison
FHTX vs PGC Comparison
Compare FHTX & PGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHTX
- PGC
- Stock Information
- Founded
- FHTX 2015
- PGC 1921
- Country
- FHTX United States
- PGC United States
- Employees
- FHTX N/A
- PGC N/A
- Industry
- FHTX Medicinal Chemicals and Botanical Products
- PGC Commercial Banks
- Sector
- FHTX Health Care
- PGC Finance
- Exchange
- FHTX Nasdaq
- PGC Nasdaq
- Market Cap
- FHTX 513.7M
- PGC 475.7M
- IPO Year
- FHTX 2020
- PGC N/A
- Fundamental
- Price
- FHTX $9.04
- PGC $36.21
- Analyst Decision
- FHTX Strong Buy
- PGC Buy
- Analyst Count
- FHTX 5
- PGC 1
- Target Price
- FHTX $16.00
- PGC $32.00
- AVG Volume (30 Days)
- FHTX 123.1K
- PGC 88.8K
- Earning Date
- FHTX 11-04-2024
- PGC 10-22-2024
- Dividend Yield
- FHTX N/A
- PGC 0.55%
- EPS Growth
- FHTX N/A
- PGC N/A
- EPS
- FHTX N/A
- PGC 1.82
- Revenue
- FHTX $25,515,000.00
- PGC $209,728,000.00
- Revenue This Year
- FHTX N/A
- PGC N/A
- Revenue Next Year
- FHTX $15.40
- PGC $17.64
- P/E Ratio
- FHTX N/A
- PGC $20.66
- Revenue Growth
- FHTX N/A
- PGC N/A
- 52 Week Low
- FHTX $2.70
- PGC $20.30
- 52 Week High
- FHTX $10.25
- PGC $37.88
- Technical
- Relative Strength Index (RSI)
- FHTX 60.32
- PGC 70.62
- Support Level
- FHTX $7.95
- PGC $31.11
- Resistance Level
- FHTX $9.54
- PGC $37.88
- Average True Range (ATR)
- FHTX 0.52
- PGC 1.51
- MACD
- FHTX 0.18
- PGC 0.44
- Stochastic Oscillator
- FHTX 79.17
- PGC 83.28
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Peapack Private Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and internet banking services. Peapack Private includes asset management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services.